Yemaachi Biotech
Business Services · Ghana · 11-50 Employees
View Company Info for Free
Overview
Headquarters
222 Swaniker St, Abelempke, Greater Accr...Phone Number
+233 502528528Website
www.yemaachi.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Yemaachi Biotech
Yemaachi Biotech is a cancer research company committed to diversifying and increasing access to precision oncology. Using cutting-edge immunogenomics, bioinformatics, and artificial intelligence, Yemaachi is dedicated to accelerating the development of cancer detection and cure strategies which have high efficacy regardless of ethnicity. Headquartered in Accra, with a growing network of partners across Africa, Yemaachi is committed to building sustainable research and community partnerships that aid in the advancement of medicine and ultimately reduce the burden of cancer in Africa. Yemaachi was one of 15 African companies to be selected as part of the Summer 2021 batch of Y Combinator.Explore more
Yemaachi Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Yemaachi Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Yemaachi Biotech launches new products
Funding: Get notified immidiatlly once Yemaachi Biotech has new funding data
Earning: See what the market has to say on Yemaachi Biotech recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Yemaachi Biotech had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Yemaachi Biotech
Yemaachi Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Yemaachi Biotech has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Yemaachi Biotech is spiking on competitors!
Recommended Actions
Find VP level buyers at Yemaachi Biotech
Find 3 more new buyers
Company Profile Activity
Activity Insights
Yemaachi Biotech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Yemaachi Biotech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Yemaachi Biotech.
Yemaachi Biotech financials insights
Gather financial insights about Yemaachi Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$3M
Yemaachi Biotech Tech Stack
A closer look at the technologies used by Yemaachi Biotech
See more technologies
Yemaachi Biotech News & Media
Yemaachi Biotechnology Launches The African Cancer Atlas, in Partnership with Roche
ACCRA, Ghana & WASHINGTON--(BUSINESS WIRE)-- #cancerresearch--Yemaachi Biotech, a pioneering genomics research company based in Ghana, announced today a partnership with Roche to launch The African Cancer Atlas (TACA). This initiative aims to address the significant underrepresentation of African genomic data in global cancer research by creating the world’s most comprehensive cancer genomic database focused on African populations, providing a foundational data set with critical insights for AfrGhana's Yemaachi Biotech and global team SAMBAI secures $25 million Cancer Grand ...
The CEO and Co-founder of Yemaachi, Yaw Bediako, along with a globally renowned interdisciplinary team of researchers, have received a prestigious Cancer Grand Challenges award, providing funding of up to $25 million over five years to advance research on cancer inequities. | Business Insider AfricaTeam SAMBAI, Yemaachi Biotech, Named as Recipient of Prestigious Cancer Grand Challenges Award
ACCRA, Ghana--(BUSINESS WIRE)-- #cancerresearch--Yemaachi today announced that a global, interdisciplinary team of researchers, including Yemaachi CEO & Co-founder Yaw Bediako, has been named a recipient of a Cancer Grand Challenges award of up to $25 million over five years to advance research on cancer inequities. “We couldn’t be prouder to be part of this global team of collaborators, tackling one of the most important challenges in cancer today—inequity in research, diagnosis, and outcomes—Yemaachi Presents Findings on Mutation Profiles of Ghanaian Women with Breast Cancer at AORTIC 2023; Announces Formation of African Clinical Cancer Research Network
DAKAR, Senegal--(BUSINESS WIRE)-- #cancerresearch--Yemaachi, the company dedicated to advancing precision oncology research and care in Africa for the benefit of patients everywhere, recently shared findings from a sequencing study in an abstract and poster presentation at the 14th AORTIC International Conference on Cancer in Africa. The study, led by Dr. Lily Paemka, represents a collaboration between Yemaachi and the Paemka Lab at the West African Centre for Cell Biology of Infectious Pathogen
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Yemaachi Biotech
Sign Up For FreeTo access detailed company insights
Yemaachi Biotech is a cancer research company committed to diversifying and increasing access to precision oncology. Using cutting-edge immunogenomics, bioinformatics, and artificial intelligence, Yemaachi is dedicated to accelerating the development of cancer detection and cure strategies which have high efficacy regardless of ethnicity. Headquart... Read More
